Welcome to the 2nd Novel Ingredients for Infant Formula & Nutrition Summit

The global infant formula market is diversifying and innovating, and so is the 2nd Novel Ingredients for Infant Formula & Nutrition Summit. This critical forum, formerly the Bioactive Infant Formula & Nutrition Summit, returns with a deeper focus on the science that underpins world-class pre-clinical and clinical development of novel bioactive ingredients and nutrients, including HMOs, MFGMs, lactoferrin, alpha-Lactalbumin, and more. Critically, it explores how this can and is supporting global regulatory success.

Uniquely positioned as an industry-led forum, this year's conference is backed by titans like Abbott Nutrition, Reckitt/Mead Johnson Nutrition, and Arla Food Ingredients, as well as emerging innovators such as Bobbie, ByHeart, Kabrita, and Checkerspot. This is your case study playbook, supporting your progression toward superior formulas. Learn strategies to engage with regulators, devise successful preclinical development approaches, benchmark clinical trial design strategies, and explore next-generation ingredients to close gaps in the nutritional, health, and immunological benefits of infant formulas.

Take advantage of focused networking with 90+ clinical development, nutrition, regulatory, and innovation leaders from infant formula manufacturers and ingredient providers, alongside academic leaders, and key service providers like CROs spearheading human milk research efforts. Leave with a scientific and regulatory roadmap to consolidate or widen your market share and join forces with your fellow industry leaders in a united effort to transform the future of infant formula.